- |||||||||| Enrollment closed, Trial primary completion date: Prevalence of Dysplasia of the Gastric Cardia (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=214, Active, not recruiting, Trial primary completion date: Mar 2015 --> Aug 2015 Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Feb 2015 --> Aug 2016
- |||||||||| Avastin (bevacizumab) / Roche
Trial primary completion date, Surgery, Metastases: Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer (clinicaltrials.gov) - Apr 19, 2015 P2, N=33, Active, not recruiting, Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Apr 2015 --> Apr 2016
- |||||||||| cisplatin / Generic mfg.
Enrollment closed, Biopsy: CHFR Methylation Status Esophageal Cancer Study (clinicaltrials.gov) - Apr 16, 2015 P2, N=56, Active, not recruiting, Enrolling by invitation --> Active, not recruiting Recruiting --> Active, not recruiting
- |||||||||| Trial primary completion date: Narrow Band Imaging Project on Barrett's Esophagus (clinicaltrials.gov) - Apr 14, 2015
P=N/A, N=50, Recruiting, Recruiting --> Completed | Trial primary completion date: Dec 2014 --> Jul 2014 Trial primary completion date: Sep 2015 --> Sep 2017
- |||||||||| Soltamox (tamoxifen citrate) / Jazz
Enrollment change: Tamoxifen to Treat Barrett's Metaplasia (clinicaltrials.gov) - Apr 14, 2015 P0, N=12, Recruiting, Trial primary completion date: Sep 2015 --> Sep 2017 N=30 --> 12
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: Proton Beam Therapy to Treat Esophageal Cancer (clinicaltrials.gov) - Apr 14, 2015
P1, N=3, Terminated, N=30 --> 12 N=40 --> 3 | Recruiting --> Terminated | Trial primary completion date: Jan 2021 --> Apr 2015; Lack of insurance coverage for proton beam treatment
- |||||||||| Trial primary completion date: Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and Cough (clinicaltrials.gov) - Apr 14, 2015
P=N/A, N=12, Recruiting, N=40 --> 3 | Recruiting --> Terminated | Trial primary completion date: Jan 2021 --> Apr 2015; Lack of insurance coverage for proton beam treatment Trial primary completion date: Dec 2014 --> Dec 2016
- |||||||||| Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
Enrollment open, Trial initiation date, Combination therapy, Metastases: FluoHeart: Effects of S-1 and Capecitabine on Coronary Artery Blood Flow (clinicaltrials.gov) - Apr 8, 2015 P2, N=40, Recruiting, Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Aug 2014 Not yet recruiting --> Recruiting | Initiation date: Aug 2014 --> Jan 2015
- |||||||||| Enrollment status: Gastroesophageal Reflux Treatment in Scleroderma (clinicaltrials.gov) - Mar 31, 2015
P3, N=250, Enrolling by invitation, Not yet recruiting --> Completed | Initiation date: Oct 2013 --> Oct 2014 | Trial primary completion date: Oct 2013 --> Mar 2015 Recruiting --> Enrolling by invitation
- |||||||||| Trial completion, Trial primary completion date: MSG and Gastrointestinal Motility (clinicaltrials.gov) - Mar 26, 2015
P=N/A, N=40, Completed, Recruiting --> Active, not recruiting | N=75 --> 4 Active, not recruiting --> Completed | Trial primary completion date: Mar 2011 --> Mar 2015
|